DiaGenic

DiaGenic is an innovative Norwegian diagnostic company that seeks to create value for patients.

DiaGenic seeks to create value for patients, partners and investors by developing innovative and patient friendly in vitro diagnostic (IVD) products for early detection of diseases. The Company’s proprietary concept implies that a disease evokes systemic responses in the blood unique for the disease, which can be measured by using blood samples. DiaGenic is a world leader in identifying gene expression signatures in blood and is focused on the development of IVD biomarker products in the field of Alzheimer’s disease (AD).